期刊文献+

小儿川崎病并发冠状动脉病变高危因素探讨 被引量:2

Investigation on the Risk Factors of Kawasaki Disease with Complication of Coronary Artery Disease in Children
下载PDF
导出
摘要 目的:探讨川崎病并发冠状动脉病变的相关因素。方法:对86例确诊为川崎病患儿的临床表现、超声心动图、急性期C—反应蛋白、胆固醇、血沉、血小板、血红蛋白、白细胞等资料进行计量资料t检验和计数资料χ2检验。结果:86例川崎病并发冠状动脉病变26例(30%)。相关因素分析显示:发病年龄、发热天数、血小板、C—反应蛋白、胆固醇与冠状动脉病变发生率有密切关系。用静脉丙种球蛋白(IVIG)治疗的冠状动脉病变发生率23.6%,仅用阿司匹林治疗的冠状动脉病变发生率57.1%,7d内使用IVIG治疗的冠状动脉病变发生率6.4%(P<0.01)。结论:对川崎病进行综合分析,可对该病作出及时的预后判断,予早期干预,促进冠状动脉病变的恢复;早期足量使用IVIG可减少KD并发冠状动脉病变的发生。 Objective: To investigate the relative rish factors for Kawasaki disease with complication of coronary artery disease. Methods: Restrospectively studied 86 children who suffered from the Kawasaki diseas. After investigating the clinical behavior, ultrasonic cardiograms and blood test results of acute prase(Including the Cholesterol ESR, CRP, Platelet, Hemoglobin, Leucocyte), we analyzed the case by t-test and chisquare test analysis. The incidence rate of coronary artery injury was 33. 3 % in cases who received WIG therapy, while 64. 2% in cases who only received aspirin therapy; but incidence rate of coronary artery injury was 9.6% in cases who received IVIG therapy within 7 days(P〈0. 013. Results: Among 86 cases, the number of patients who got the complication of coronary artery disease was 26(30%). After analyzing the risk factors we find that fever duration,platelet,CRP,Cholesterol had Close relationship with the disease of coronary artery(P 〈0.01). Conclusion: With help of medical analysis on the disease and combining the positive physical and laboratory findings,we can timely pre-diagnose the disease and give appropriate treatment in advance to prevent coronary artery disease and help the recovery of pathological changes for coronary artery; full-dose IVIG therapy in early stage can reduce the incidence of coronary artery injure.
出处 《河北北方学院学报(医学版)》 2006年第2期43-45,共3页 Journal of Hebei North University:Medical Edition
关键词 川崎病 冠状动脉病变 危险因素 Kawasaki disease Coronary artery Risk factor
  • 相关文献

参考文献9

二级参考文献20

  • 1孙涛,李永柏,刘淑英,陈维金,杨红育,聂荣国,杨锡强.免疫球蛋白治疗皮肤粘膜淋巴结综合征[J].中华医学杂志,1996,76(1):64-65. 被引量:22
  • 2于宪一.川崎病心血管损伤检查的进展[J].国外医学(儿科学分册),1996,23(6):313-316. 被引量:4
  • 3孙涛 李永柏 等.静脉注射免疫蛋白治疗川崎病的临床与实验室观察[J].上海免疫学杂志,1996,5:290-292.
  • 4[1]Kim H, Yamaguchi H, Inamo K, et al. Changes in apolipoproteins during the acute phase of KD.Acta paediatr Jpn, 1995, 37(6): 672- 676.
  • 5[2]Cabana VG, Gidding SS, Getz GS, et al. Serum amyloid A and high density lipoprotein participate in the acute phase response of KD. Pediatr Res, 1997, 42(5): 651-655.
  • 6[3]Siemianowicz K, Gminski J, Stajszczyk M, et al. Serum total cholesterol and triglycerides levels in patients with lung cancer. Int J Mol Med,2000, 5(2) : 201 -205.
  • 7[4]Yoshioka T, Matsutani T, Iuagami S, et al , poly-clonal expansion of TCRBV2-and TCRBV6-bearing T cells in patients with Kawaski disease. Immunology, 1999, 96(3): 465-472.
  • 8[5]Fraunberger P, Pilz G, Cremer P, et al. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock, 1998, 10(5) :359- 363.
  • 9[6]Bentz MH, Magnette J. Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin(120 cases). Rev Med Intern, 1998, 19(3): 168-172.
  • 10[7]McConnell ME, Hannon DW, Steed RD, et al. Fatal obliterative coronary vasculitis in Kawasaki disease. J Pediatr, 1998, 133(2): 259- 261.

共引文献231

同被引文献17

  • 1王垒,杨增芳,马巧梅,董宁.川崎病并发冠状动脉扩张的临床危险因素分析[J].陕西医学杂志,2004,33(10):888-889. 被引量:5
  • 2黄国英.川崎病流行病学现状[J].中国实用儿科杂志,2006,21(10):721-723. 被引量:46
  • 3张永兰,杜忠东.小儿川崎病冠状动脉损伤的危险因素[J].中国实用儿科杂志,2006,21(10):742-744. 被引量:48
  • 4Honkanen V E,McCrindle BW,Laxer RaM,et al.Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease[J].Pediatr Cardiol,2003,24(2): 122-126.
  • 5Research Committee on Kawasaki disease.Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease[M].Tokyo: Ministry of Health and Welfare, 1984.
  • 6Newberger JW,Takahashi M,Gerber MA, et al.Diagnosis, treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis,and Kawasaki Disease, Council on Cardiovascular Disease in the Young American Heart Association[J].Pediatrics,2004,114:1708-1733.
  • 7Kim DS,Han BH,Lee SK,et al.Evidence for selection of 11 amino acid CDR3 domains in V kappa Ⅲ-derived immuno-globulin light chairs in Kawasaki disease[J].Scand J Rhematol, 1997;26:350-354.
  • 8Rowley AH,Shulman ST.Kawasaki disease.In:Behrman RE,Kidman RM,Alvin AM,eds.Nelson textbook of Pediatrics.Philadelphia:Saunders,2000:725-727.
  • 9Behman RE,Kliegman RM,Arvin AM,et al.Nelson textbook of pediatrics. Philadeiphia:Saunders,2000;725-727.
  • 10吴瑞萍,胡亚蔓,江载芳.诸福棠实用儿科学[M].第七版.北京:人民卫生出版社,2002:698-705.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部